|
Complete CRRT Brochure PDF (728K)
|
|
|
|
|
|
|
|
|
Wednesday, February 27
|
|
|
|
|
|
|
|
|
|
|
7:00am
|
Registration for Wednesday's Hands-On Workshop
|
|
|
|
|
|
|
|
|
|
8:00-5:15
|
FULL DAY CONCURRENT WORKSHOPS
|
|
|
|
|
|
|
|
|
|
Full Day Concurrent Workshops- H01 & H02
|
8:00-5:15
|
|
|
|
|
|
|
|
8:00-5:15
|
H01 Gambro Prismaflex Hands-On Workshop
|
|
|
|
|
|
Training on setup, connections, operations, monitoring and troubleshooting for the Prismaflex platform systems for patients requiring various modalities of CRRT.
|
|
|
|
8:00-10:15
|
Session 1
|
|
|
|
|
|
|
|
|
|
10:15-10:30
|
Coffee Break
|
|
|
|
|
|
|
|
|
|
10:30-12:30
|
Session 2
|
|
|
|
|
|
|
|
|
|
12:30-1:30
|
Lunch Hosted by Conference for Workshop Participants
|
|
|
|
|
|
|
|
|
|
1:30-3:15
|
Session 3
|
|
|
|
|
|
|
|
|
|
3:15-3:30
|
Coffee Break
|
|
|
|
|
|
|
|
|
|
3:30-5:15
|
Session 4
|
|
|
|
|
|
|
|
|
|
8:00-5:15
|
H02 Fundamentals of CRRT
|
|
|
|
|
|
This workshop offers an introduction to CRRT techniques and is developed to provide a core set of information on the principles and practice of CRRT. This workshop will cover the components and basic principles of continuous renal replacement therapy. The operating characteristics of CRRT techniques for solute and fluid management, drug management will be discussed along with the potential applications of these techniques. Requirements for developing a successful CRRT program and selecting machines will also be described.
|
|
|
|
8:00-8:40
|
Operating Principles of CRRT
|
|
|
William R. Clark, MD
|
|
|
|
|
|
|
8:40-9:20
|
Access/Membrane and Circuit
|
|
|
Michael A. Kraus, MD
|
|
|
|
|
|
|
9:20-10:00
|
Anticoagulation
|
|
|
Andrew Davenport, MD, FRCP
|
|
|
|
|
|
|
10:00-10:15
|
Discussion
|
|
|
|
|
|
|
|
|
|
10:15-10:30
|
Coffee Break
|
|
|
|
|
|
|
|
|
|
10:30-11:10
|
Solute Control and Dose
|
|
|
William R. Clark, MD
|
|
|
|
|
|
|
11:10-11:50
|
Solutions: Replacement & Dialysate
|
|
|
Michael A. Kraus, MD
|
|
|
|
|
|
|
11:50-12:15
|
Fluid Management
|
|
|
Ravindra L. Mehta, MBBS, MD, DM, FACP
|
|
|
|
|
|
|
12:15-12:30
|
Discussion
|
|
|
|
|
|
|
|
|
|
12:30-1:30
|
Lunch Hosted by Conference for Workshop Participants
|
|
|
|
|
|
|
|
|
|
1:30-2:10
|
Drug Management
|
|
|
Bruce A. Mueller, PharmD, FCCP
|
|
|
|
|
|
|
2:10-3:00
|
Patient Selections and Outcomes
|
|
|
Emil P. Paganini, MD, FACP, FRCP
|
|
|
|
|
|
|
3:00-3:15
|
Discussion
|
|
|
|
|
|
|
|
|
|
3:15-3:30
|
Coffee Break
|
|
|
|
|
|
|
|
|
|
3:30-4:10
|
Organizational and Financial Aspects
|
|
|
Jorge Cerda, MD, FACP, FASN
|
|
|
|
|
|
|
4:10-5:15
|
CRRT Machine Comparisons
|
|
|
|
|
|
|
|
|
|
8:00-5:15pm
|
HALF DAY WORKSHOPS
(concurrent with HO1 and HO2)
|
|
|
|
|
|
|
|
|
|
Half Day Concurrent Workshops-H03
|
8:00-12:30
|
|
|
|
|
|
|
|
8:00-12:30
|
H03 Pediatric CRRT
|
|
|
Patrick D. Brophy, MD, FAAP, FRCPC Helen Currier, BSN, RN, CNN Stuart L. Goldstein, MD Michael Zappitelli, MD, MSc
|
|
|
How to prescribe and deliver CRRT for neonates and pediatric patients, including machine setup, operations, monitoring and managing alarm conditions.
|
|
|
|
10:15-10:30
|
Coffee Break
|
|
|
|
|
|
|
|
|
|
10:30-12:30
|
Pediatric CRRT (continued)
|
|
|
|
|
|
|
|
|
|
12:30-1:30
|
Lunch Hosted by Conference for Workshop Participants
|
|
|
|
|
|
|
|
|
|
Half Day Concurrent Workshops-H04
|
1:30-5:15
|
|
|
|
|
|
|
|
1:30-5:15
|
H04 Baxter Healthcare Corporation
|
|
|
Lee C. Ware, RN
|
|
|
An in-depth review of the new Aquarius instrument for CRRT & TPE demonstrates how to treat a wide range of patients with advanced therapy options, backed by Baxter's clinical support, technical services and enhanced offerings. Competence, Constancy, Confidence.
|
|
|
|
3:15-3:30
|
Coffee Break
|
|
|
|
|
|
|
|
|
|
3:30-5:15
|
Baxter Healthcare Corporation (continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Thursday Morning, February 28
|
|
|
|
|
|
|
|
|
|
|
7:00am-7:30pm
|
Registration
|
|
|
|
|
|
|
|
|
|
8:00am-11:30am
|
WORKSHOPS
|
|
|
|
|
|
(open to all participants - applicable to physicians, nurses and allied personnel) (Codes: C= Core workshop, I = Intermediate, A = Advanced, N= Nurses, AP = of interest to nurses and allied personnel) Workshops designated by an asterisk (*) will be presented twice in different time slots. Workshops presented in a series are marked with a "1" for a primary workshop discussion in this area and "2" for a more complex or advanced discussion in this area. Please note that the series workshops 1 and 2 can be either taken subsequently (following each other) or they can each be taken independently (e.g. workshop 1 can be taken without taking workshop 2 and vice versa).
|
|
|
|
Workshop Group 1
|
8:00-9:30
|
|
|
|
|
|
|
|
8:00-9:30
|
A01 CRRT Systems I
I. B.Braun Diapact II
|
|
|
John Barnes, RN, CCRN
|
|
|
Device demonstrations of features, setup, operation, monitoring and discontinuation. Please note A01 is a two part workshop - 45 minutes in each (A01 I & A01 II)
|
|
|
|
8:00-9:30
|
A01 CRRT Systems I
II. Baxter Healthcare Aquarius System
|
|
|
Christopher Peticca, Sr. CRRT Account Exe
|
|
|
Device demonstrations of features, setup, operation, monitoring and discontinuation. Please note A01 is a two part workshop - 45 minutes in each (A01 I & A01 II)
|
|
|
|
8:00-9:30
|
B02 Vascular Access /Membrane and Circuit 1
|
|
|
Nigel Fealy, RN, MN, ACCCN Michael A. Kraus, MD Eileen Lischer, RN BSN MA
|
|
|
Principles of catheter choice, placement, maintenance, recognition and management of complications, selection and use of membranes for different applications, circuit design, setup and monitoring
|
|
|
|
8:00-9:30
|
C03 Dialysis Dose Prescription and Delivery
|
|
|
William R. Clark, MD Claudio Ronco, MD
|
|
|
Operational characteristics influencing solute removal in CRRT
|
|
|
|
8:00-9:30
|
D04 Critical Care Pharamacology: Vasopresors, and Ionotropes
|
|
|
Patrick T. Murray, MD Andrew D. Shaw, MD FRCA FCCM
|
|
|
Pathophysiology of shock and the principles and practical use of vasopressors, ionotropes , vasodilators in critically ill patients.
|
|
|
|
8:00-9:30
|
E05 Organizational Aspects of CRRT Programs
|
|
|
Jorge Cerda, MD, FACP, FASN Emil P. Paganini, MD, FACP, FRCP
|
|
|
Practical issues for organization and implementation of a CRRT program. Developing and implementing policies and protocols for CRRT. Multidisciplinary teams, collaborative precatice, Finanical models and other strategies for succsess
|
|
|
|
8:00-9:30
|
F06 Extracorporeal Techniques for Sepsis 1: Pathophysiology and Targets
|
|
|
Hiroyuki Hirasawa, MD John A. Kellum, MD William L. Macias, MD, PhD
|
|
|
Pathophysiology of sepsis and rationale for use of extracorporeal support in treatment of sepsis. Experimental models for high permeability membranes, HVHF, VHVHF and hybrid therapies"
|
|
|
|
8:00-9:30
|
G07 Biomarkers: Principles and Applications
|
|
|
Lakhmir S. Chawla, MD Prasad Devarajan, MD
|
|
|
Principles and classification of biomarkers and their application for diagnosis and management of diseases. Criteria for using biomarkers as surrogate end points.
|
|
|
|
8:00-9:30
|
H08 CRRT Systems II
I. NxStage Therapy System
|
|
|
Christopher Kontzen
|
|
|
Device demonstrations of features, setup, operation, monitoring and discontinuation. Please note H08 is a two part workshop - 45 minutes in each (H08 I & H08 II).
|
|
|
|
8:00-9:30
|
H08 CRRT Systems II
II. Gambro
|
|
|
|
|
|
Device demonstrations of features, setup, operation, monitoring and discontinuation. Please note H08 is a two part workshop - 45 minutes in each (H08 I & H08 II).
|
|
|
|
9:30-10:00
|
Coffee Break
|
|
|
|
|
|
|
|
|
|
Workshop Group 2
|
10:00-11:30
|
|
|
|
|
|
|
|
10:00-11:30
|
A09a CRRT Systems III
Fresenius
|
|
|
Christian Schlaeper, MS
|
|
|
Device demonstrations of features, setup, operation, monitoring and discontinuation.
Please note this workshop runs the full 1 1/2 hours and is simultaneous with A09b
|
|
|
|
10:00-11:30
|
A09b CRRT Systems III
Solutions for CRRT 1: Practical Issues
|
|
|
Edward Ross, MD Sheldon W. Tobe, MD, FRCP(C)
|
|
|
Solutions of various compositions will be compared and the rational for
selecting bicarbonate based solutions and electrolyte composition of
solutions will be described. The effect of the composition of solutions
on metabolic control particularly in higher flow prescriptions will be
reviewed.
These principles will be expanded in a case based format in Workshop
A25.
Please note this workshop runs the full 1 1/2 hours and is simultaneous with A09a
|
|
|
|
10:00-11:30
|
B10 Anticoagulation: Mechanisms and Techniques
|
|
|
Andrew Davenport, MD, FRCP Ashita Tolwani, MD
|
|
|
Anticoagulation regimens: Mechanisms, selection, prescription, monitoring and implementation
|
|
|
|
10:00-11:30
|
C11 Fluid Management
|
|
|
Ravindra L. Mehta, MBBS, MD, DM, FACP
|
|
|
Principles of volume assessment, fluid removal and fluid regulation with different CRRT equipment
|
|
|
|
10:00-11:30
|
D12 Critical Care Management: Nutrition Assessment and Delivery
|
|
|
Oliver Joannes-Boyau, MD Greet Van Den Berghe, MD, PhD
|
|
|
Pathophysiology of malnutrition in critically ill patients. Principles of nutritional assessment and support and adjustments for RRT.
|
|
|
|
10:00-11:30
|
E13 Competency Assessment in CRRT
|
|
|
Patty Graham, RN, MS, CCRN, CS Eileen Lischer, RN BSN MA
|
|
|
Description on training requirements, core curriclulum and skills assessment for CRRT care delivery.
|
|
|
|
10:00-11:30
|
F14 Liver and the Kidney 1: Principles of Hepatic Dysfunction
|
|
|
Tarek Hassanein, MD Michael Joannidis, MD
|
|
|
Pathophysiology of hepatic failure and rationale for use of different techniques for extracorporeal support techniques (Cell based systems, MARS, CRRT) for hepatic support
|
|
|
|
10:00-11:30
|
G15 Therapy Comparisons : SLED vs. CRRT vs. PD
|
|
|
Rajasekara Chakravarthi, MD, DNB (Nephrology) Thomas A. Golper, MD Mark R. Marshall, MBChB, FRACP
|
|
|
Comparisons of operational characteristics including anticoagulation, membranes, solutions and flows and approaches for ongoing and future research
|
|
|
|
10:00-11:30
|
H16 Pediatric CRRT: The Basics
|
|
|
Steven R. Alexander, MD Patrick D. Brophy, MD, FAAP, FRCPC John J. Gardner, RN Stuart L. Goldstein, MD Michael Zappitelli, MD, MSc
|
|
|
Technique requirement and application for use in children including neonates. Practical issues for setting up and maintaining a pediatric CRRT program. Policies and procedures and protocol based management
|
|
|
|
11:30-1:00
|
Lunch Hosted by Conference
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Thursday Afternoon, February 28
|
|
|
|
|
|
|
|
|
|
|
|
SESSION I: PATIENT CHARACTERISTICS
|
|
|
|
|
|
|
|
|
|
1:00-1:10
|
Opening Remarks
|
|
|
Ravindra L. Mehta, MBBS, MD, DM, FACP
|
|
|
|
|
|
|
Plenary 1 MINI-SYMPOSIA Organ Dysfunction in the Critically Ill Patient: Emerging Concepts
|
1:00-3:30
|
|
|
|
|
|
|
|
1:10-1:30
|
Glycemic Control: Does it Matter?
|
|
|
Greet Van Den Berghe, MD, PhD
|
|
|
|
|
|
|
1:30-1:50
|
Endothelial Dysfunction: The Common Pathway to MODS?
|
|
|
William L. Macias, MD, PhD
|
|
|
|
|
|
|
1:50-2:10
|
Acute Pancreatitis: Pathophysiology and Management
|
|
|
Hiroyuki Hirasawa, MD
|
|
|
|
|
|
|
2:10-2:30
|
Disordered Tissue Perfusion
|
|
|
Emanuel Rivers, MD
|
|
|
|
|
|
|
2:30-2:50
|
Liver Dysfunction in Critical Illness
|
|
|
Tarek Hassanein, MD
|
|
|
|
|
|
|
2:50-3:15
|
SPECIAL LECTURE Endocrine Manifestations of Critical Illness
|
|
|
Greet Van Den Berghe, MD, PhD
|
|
|
|
|
|
|
3:15-3:30
|
Panel Discussion
|
|
|
|
|
|
|
|
|
|
3:30-4:00
|
Coffee Break - Exhibits Open
|
|
|
|
|
|
|
|
|
|
Plenary 2 MINI-SYMPOSIA Acute Kidney Injury (AKI): Pathophysiology
|
4:00-6:00
|
|
|
|
|
|
|
|
4:00-4:20
|
Pathogenesis of AKI: What Have We Learned From Biomarkers?
|
|
|
Prasad Devarajan, MD
|
|
|
|
|
|
|
4:20-4:40
|
Contrast Nephropathy: Epidemiology and Prognosis
|
|
|
Peter A. McCullough, MD, MPH
|
|
|
|
|
|
|
4:40-5:00
|
Post Cardiac Surgery AKI: the EVOLVE Study
|
|
|
Emil P. Paganini, MD, FACP, FRCP
|
|
|
|
|
|
|
5:00-5:20
|
What Happens in the Operating Room?
|
|
|
Andrew D. Shaw, MD FRCA FCCM
|
|
|
|
|
|
|
5:20-5:45
|
SPECIAL LECTURE Sepsis-Induced AKI: Natural History and Relationship to Inflammatory Response
|
|
|
John A. Kellum, MD
|
|
|
|
|
|
|
5:45-6:00
|
Panel Discussion
|
|
|
|
|
|
|
|
|
|
6:00
|
Adjourn
|
|
|
|
|
|
|
|
|
|
6:00-7:30
|
Exhibit Reception and Poster Session
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Friday Morning, February 29
|
|
|
|
|
|
|
|
|
|
|
7:00am-4:00pm
|
Registration
|
|
|
|
|
|
|
|
|
|
|
SESSION II: EMERGING CONCEPTS IN AKI AND CRITICAL CARE
|
|
|
|
|
|
|
|
|
|
7:25-7:30
|
Announcements
|
|
|
Ravindra L. Mehta, MBBS, MD, DM, FACP
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Plenary 3 MINI-SYMPOSIA Controversies in Management of the Critically Ill Patient
|
7:30-9:45
|
|
|
|
|
|
|
|
7:30-7:50
|
Targeted Resuscitation: Strategies for Success
|
|
|
Emanuel Rivers, MD
|
|
|
|
|
|
|
7:50-8:10
|
Multi Organ Failure or Multi Organ Success
|
|
|
Mervyn Singer, MD
|
|
|
|
|
|
|
8:10-8:25
|
Lung Kidney Interactions: Clinical Correlations
|
|
|
Stuart L. Goldstein, MD
|
|
|
|
|
|
|
8:25-8:40
|
Lung Kidney Interactions: Mechanisms and Pathways
|
|
|
Hamid Rabb, MD, FACP
|
|
|
|
|
|
|
8:40-9:00
|
Maintaining Renal Perfusion:What Works?
|
|
|
Patrick T. Murray, MD
|
|
|
|
|
|
|
9:00-9:30
|
SPECIAL LECTURE Sepsis Induced Organ Dysfunction: Strategies for Prevention and Treatment
|
|
|
Mervyn Singer, MD
|
|
|
|
|
|
|
9:30-9:45
|
Panel Discussion
|
|
|
|
|
|
|
|
|
|
9:45-10:15
|
Coffee Break
|
|
|
|
|
|
|
|
|
|
Plenary 4 MINI-SYMPOSIA Emerging Concepts in AKI
|
10:15-12:45
|
|
|
|
|
|
|
|
10:15-10:35
|
Bench to Bedside: What's New in AKI?
|
|
|
Hamid Rabb, MD, FACP
|
|
|
|
|
|
|
10:35-10:55
|
Early Intervention in AKI: Is Erythropoietin Beneficial?
|
|
|
Zoltan Endre, MD, PhD
|
|
|
|
|
|
|
10:55-11:15
|
Heart Failure and the Kidney
|
|
|
Gregg C. Fonarow, MD
|
|
|
|
|
|
|
11:15-11:35
|
Cardiorenal Syndrome: Do We Know What it is?
|
|
|
Claudio Ronco, MD
|
|
|
|
|
|
|
11:35-11:55
|
AKI in the Tropics: What Have We Learned?
|
|
|
Emmanuel Burdmann, MD, PhD
|
|
|
|
|
|
|
11:55-12:15
|
Risk Assessment for AKI: The Evolving Toolkit
|
|
|
Lakhmir S. Chawla, MD
|
|
|
|
|
|
|
12:15-12:35
|
AKI and CKD: Cause or Consequence?
|
|
|
Ravindra L. Mehta, MBBS, MD, DM, FACP
|
|
|
|
|
|
|
12:35-12:45
|
Panel Discussion
|
|
|
|
|
|
|
|
|
|
12:45-2:15
|
Lunch Hosted by Conference
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Friday Afternoon, February 29
|
|
|
|
|
|
|
|
|
|
|
2:15-5:45
|
WORKSHOPS
|
|
|
|
|
|
|
|
|
|
Workshop Group 3
|
2:15-3:45
|
|
|
|
|
|
|
|
2:15-3:45
|
A17 CRRT Systems I
I. B. Braun Diapact
|
|
|
John Barnes, RN, CCRN
|
|
|
Device demonstrations of features, setup, operation, monitoring and discontinuation.
Please note A17 is a two part workshop - 45 minutes in each (A17 I & A17 II).
|
|
|
|
2:15-3:45
|
A17 CRRT Systems I
II. Baxter Healthcare Aquarius System
|
|
|
Christopher Peticca, Sr. CRRT Account Exe
|
|
|
Device demonstrations of features, setup, operation, monitoring and discontinuation. Please note A17 is a two part workshop - 45 minutes in each (A17 I & A17 II).
|
|
|
|
2:15-3:45
|
B18 Drug Management in CRRT
|
|
|
Bruce A. Mueller, PharmD, FCCP Miet Schetz, MD, PhD
|
|
|
Drug Dosing principles for critically ill patients and adjustments in extracorporeal support techniques.
|
|
|
|
2:15-3:45
|
C19 Timing of Initiation for RRT: Principles and Practice
|
|
|
Emmanuel Burdmann, MD, PhD Ravindra L. Mehta, MBBS, MD, DM, FACP Paul Palevsky, MD
|
|
|
Principles of determining when to start and stop RRT. Case based dsicussion of various approaches.
|
|
|
|
2:15-3:45
|
D20 Principles of Resuscitation
|
|
|
Daniel Davis, MD Patty Graham, RN, MS, CCRN, CS Emanuel Rivers, MD
|
|
|
Principles of resuscitation for the critically ill patient
|
|
|
|
2:15-3:45
|
E21 Acid Base and Electrolyte Problems in the Critically Ill 1
|
|
|
Andrew Davenport, MD, FRCP Stuart L. Goldstein, MD John A. Kellum, MD
|
|
|
Case based discussions of applications of solutions for acid-base and metabolic control.
|
|
|
|
2:15-3:45
|
F22 Heart Failure and Cardio-Renal Syndrome 1: Pathophysiology
|
|
|
Gregg C. Fonarow, MD Peter A. McCullough, MD, MPH James A. Tumlin, MD
|
|
|
Pathophysiology, recognition and management strategies for cardiac and renal failure in the critically ill patient
|
|
|
|
2:15-3:45
|
G23 Extracorporeal Techniques for Sepsis 2
|
|
|
Patrick M. HonorČ, MD Oliver Joannes-Boyau, MD Mervyn Singer, MD
|
|
|
Technical considerations and practical application of extracorporeal support techniques for sepsis. Results of human studies for use of high permeability membranes, HVHF, VHVHF and hybrid techniques for sepsis
|
|
|
|
2:15-3:45
|
H24 CRRT Systems II
I. NxStage Therapy System
|
|
|
Christopher Kontzen
|
|
|
Device demonstrations of features, setup, operation, monitoring and discontinuation. Please note H24 is a two part workshop - 45 minutes in each (H24 I & H24 II).
|
|
|
|
2:15-3:45
|
H24 CRRT Systems II
II. Gambro
|
|
|
|
|
|
Device demonstrations of features, setup, operation, monitoring and discontinuation. Please note H24 is a two part workshop - 45 minutes in each (H24 I & H24 II).
|
|
|
|
3:45-4:15
|
Coffee Break
|
|
|
|
|
|
|
|
|
|
Workshop Group 4
|
4:15-5:45
|
|
|
|
|
|
|
|
4:15-5:45
|
A25a CRRT Systems III
Fresenius
|
|
|
Christian Schlaeper, MS
|
|
|
Fresenius:Device demonstrations of features, setup, operation, monitoring and discontinuation. Please note this workshop runs the full 1 1/2 hours and is simultaneous with A25b
|
|
|
|
4:15-5:45
|
A25b CRRT Systems III
Solutions for CRRT 2
|
|
|
Geoff Sheinfeld Balazs Szamosfalvi, MD Sheldon W. Tobe, MD, FRCP(C)
|
|
|
This workshop complements workshop A09b that describes the basic concepts
for formulation and application of various solutions in CRRT. Cases
illustrate the practical approaches for achieving metabolic, acid-base,
electrolyte and divalent ion control and complications related to the
use of solutions and regional citrate anticoagulation.
Please note this workshop runs the full 1 1/2 hours and is simultaneous with A25a
|
|
|
|
4:15-5:45
|
B26 Acid Base and Electrolyte Problems in the Critically Ill 2
|
|
|
Noel Gibney, MD Thomas A. Golper, MD Paul Palevsky, MD
|
|
|
Case based discussion of management of common electrolyte and divalent ion problems in criticaly ill patients
|
|
|
|
4:15-5:45
|
C27 Plasma Exchange Therapy and Hybrid Techniques
|
|
|
Hiroyuki Hirasawa, MD Oliver Joannes-Boyau, MD Andre A. Kaplan, MD David M. Ward, MD, FRCP
|
|
|
Principles of plasma exchange, sorbent based and hybrid therapies for extracorporeal support. Case based discussion of practical application of plasma exchange, sorbent based and hybrid therapies for extracorporeal support.
|
|
|
|
4:15-5:45
|
D28 Hemodynamic Monitoring: Principles and Practice
|
|
|
Michael Joannidis, MD Peter A. McCullough, MD, MPH Andrew D. Shaw, MD FRCA FCCM
|
|
|
Principles of hemodynamic monitoring uding invasive and non-invasive techniques for assessment.
|
|
|
|
4:15-5:45
|
E29 A Systems-based Approach to CRRT
|
|
|
Linda Awdishu, PharmD, MAS Ravindra L. Mehta, MBBS, MD, DM, FACP
|
|
|
Principles of systems based management strategies and their application to CRRT. Approaches to reduce errors in therapy prescription and delivery
|
|
|
|
4:15-5:45
|
F30 Heart Failure and Cardio-Renal Syndrome 2
|
|
|
Gregg C. Fonarow, MD Michael A. Kraus, MD
|
|
|
Technical considerations, practical application and results of different methods to treat heart failure and cardio-renal syndrome
|
|
|
|
4:15-5:45
|
G31 Liver and Kidney 2: Hepatic Support
|
|
|
Tarek Hassanein, MD
|
|
|
Technical considerations, practical application and results of different methods of hepatic support for patients with hepatic failure and hepatorenal syndrome
|
|
|
|
4:15-5:45
|
H32 CRRT for Metabolic Disorders and Intoxications
|
|
|
John J. Bissler, MD James Fortenberry, MD
|
|
|
Pathophysiology and managemnt of metabolic disorders and intoxications with CRRT
|
|
|
|
5:45
|
Adjourn
|
|
|
|
|
|
|
|
|
|
6:30
|
Social Outing-Night at the Science Museum
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Saturday Morning, March 1
|
|
|
|
|
|
|
|
|
|
|
7:00-5:00
|
Registration
|
|
|
|
|
|
|
|
|
|
|
SESSION III: TECHNIQUE CHARACTERISTICS
|
|
|
|
|
|
|
|
|
|
7:25-7:30
|
Announcements
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Plenary 5 MINI SYMPOSIA Challenges and Controversies in Renal Support and CRRT
|
7:30-10:00
|
|
|
|
|
|
|
|
7:30-7:50
|
Dialysis Dose: Can We Compare Therapies?
|
|
|
Claudio Ronco, MD
|
|
|
|
|
|
|
7:50-8:10
|
Intensity of Dialysis: Does it Matter?
|
|
|
Paul Palevsky, MD
|
|
|
|
|
|
|
8:10-8:30
|
When to Start and When to Stop RRT in the Critically Ill?
|
|
|
Ravindra L. Mehta, MBBS, MD, DM, FACP
|
|
|
|
|
|
|
8:30-8:45
|
Anticoagulation In CRRT: An Update
|
|
|
Miet Schetz, MD, PhD
|
|
|
|
|
|
|
8:45-9:00
|
Plasma Exchange, CRRT and Sepsis: The TAMOV Trial
|
|
|
James Fortenberry, MD
|
|
|
|
|
|
|
9:00-9:15
|
Care Delivery Models: Nursing Care for CRRT
|
|
|
Nigel Fealy, RN, MN, ACCCN
|
|
|
|
|
|
|
9:15-9:45
|
SPECIAL LECTURE Debate: Immunomodulation with CRRT: Fact or Fantasy
|
|
|
Patrick M. HonorČ, MD Michael Joannidis, MD
|
|
|
|
|
|
|
9:45-10:00
|
Panel Discussion
|
|
|
|
|
|
|
|
|
|
10:00-10:30
|
Coffee Break
|
|
|
|
|
|
|
|
|
|
|
SESSION IV: FUTURE TRENDS IN CRRT AND CRITICAL CARE
|
|
|
|
|
|
|
|
|
|
Plenary 6 MINI SYMPOSIA Emerging Strategies in AKI and Extracorporeal Support
|
10:30-1:00
|
|
|
|
|
|
|
|
10:30-10:50
|
Current Status of Blood Purification in Critical Care in Japan
|
|
|
Kazou Kaizu, MD
|
|
|
|
|
|
|
10:50-11:10
|
Targeted Renal Therapy: A New Approach to Prevention and Treatment of AKI
|
|
|
James A. Tumlin, MD
|
|
|
|
|
|
|
11:10-11:30
|
Advances in Imaging Technology
|
|
|
Zoltan Endre, MD, PhD
|
|
|
|
|
|
|
11:30-11:50
|
Feedback Loops for Filtration Control
|
|
|
John J. Bissler, MD
|
|
|
|
|
|
|
11:50-12:10
|
Advances in Renal Support: Literature Review
|
|
|
Paul Palevsky, MD
|
|
|
|
|
|
|
12:10-12:30
|
Dialysis in Developing World: Challenges and Opportunities
|
|
|
Rajasekara Chakravarthi, MD, DNB (Nephrology)
|
|
|
|
|
|
|
12:30-12:50
|
Research Prerogatives in AKI and Renal Support
|
|
|
John A. Kellum, MD
|
|
|
|
|
|
|
12:50-1:00
|
Panel Discussion
|
|
|
|
|
|
|
|
|
|
1:00
|
Closing Remarks
|
|
|
Ravindra L. Mehta, MBBS, MD, DM, FACP
|
|
|
|
|
|
|
1:05
|
Conference Adjourns
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Saturday Afternoon, March 1
|
|
|
|
|
|
|
|
|
|
|
|
CONCURRENT ELECTIVE HANDS-ON WORKSHOPS
|
|
|
|
|
|
|
|
|
|
1:05-2:00
|
Lunch Hosted by Conference for Workshop Participants
|
|
|
|
|
|
|
|
|
|
Concurrent Elective Hands-On Workshops
|
2:00-5:30
|
|
|
|
|
|
|
|
2:00-5:30
|
H05 CRRT With Gambro Prismaflex
|
|
|
|
|
|
This is a slightly condensed version of its original form presented on Wednesday (HO1). Training on setup, connections, operations,monitoring and troubleshooting for the Prismaflex platform systems for patients requiring various modalities of CRRT.
|
|
|
|
2:00-5:30
|
H06 Fresenius Workshop "SLED, CRRT and IHD with the 2008K"
|
|
|
|
|
|
Learn how to use the Fresenius system for SLED, CRRT and IHD for acute renal failure.
|
|
|
|
2:00-5:30
|
H07 Resuscitation: Principles and Practice
|
|
|
Daniel Davis, MD Patty Graham, RN, MS, CCRN, CS
|
|
|
An interactive hands-on workshop covering the general approach to resuscitation and emerging concepts in resuscitation science. Case studies will be used to illustrate various principles and management of common scenerios. Skills performed on SIM_MAN a high-fidelity human patient simulator.
|
|
|
|
2:00-3:30
|
Session 1
|
|
|
|
|
|
|
|
|
|
3:30-3:45
|
Coffee Break
|
|
|
|
|
|
|
|
|
|
3:45-5:30
|
Session 2
|
|
|
|
|
|
|
|
|
|
5:30
|
Workshops Adjourn
|
|
|
|
|
|
|